Drainless Thyroidectomy by the Sutureless Technique for Benign Thyroid Diseases
Safety and Feasibility of Drainless Thyroid Surgery for Benign Thyroid Diseases Using the Sutureless Technique, Rrandomized Controlled Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Thyroidectomy for benign thyroid diseases is commonly performed with routine placement of surgical drains to prevent postoperative hematoma or seroma. However, drain use may be associated with increased pain, infection risk, prolonged hospital stay, and patient discomfort. Advances in surgical techniques, particularly the use of sutureless energy-based hemostatic devices, have raised the possibility of safely omitting routine drain placement in selected patients.
This prospective randomized controlled trial aims to assess the safety and feasibility of drainless thyroid surgery in patients with benign thyroid diseases. Eligible patients undergoing thyroidectomy are randomly allocated into two groups: a drainless group, in which no postoperative drain is inserted, and a control group, in which a conventional closed suction drain is placed.
All surgeries are performed using a standardized sutureless technique for hemostasis. Patients are followed postoperatively to evaluate surgical and clinical outcomes, including postoperative bleeding or hematoma, seroma formation, wound complications, hypocalcemia, recurrent laryngeal nerve injury, postoperative pain, length of hospital stay, and need for reintervention or readmission.
The results of this study are expected to clarify whether drainless thyroid surgery using a sutureless technique is a safe and feasible alternative to conventional drain placement in benign thyroid surgery and may help optimize postoperative care and patient comfort
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Minya, Egypten, 61111
- Minia University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Adult patients (≥18 years)
- Benign thyroid disease confirmed by: clinical assessment, ultrasonography, and fine-needle aspiration cytology (Bethesda II)
- Indicated for elective hemithyroidectomy or total thyroidectomy
- Euthyroid or adequately controlled thyroid function
Exclusion Criteria:
- Thyroid malignancy or indeterminate cytology
- Re-operative thyroid surgery
- Retrosternal goiter
- Coagulation disorders
- Patients on anticoagulation that could not be safely discontinued
- Concomitant neck surgery
- Severe uncontrolled systemic illness (ASA IV or higher)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: thyroidectomy without drain
Participants in this arm undergo sutureless thyroidectomy procedure, but no surgical drain is placed afterward.
The aim is to evaluate whether omitting the drain affects outcomes such as postoperative surgical site complications (like pain, infection, seroma, hematoma) compared with the drained approach.
|
Participants undergo sutureless thyroidectomy procedure but no drain is placed postoperatively.
The goal is to assess whether omitting the drain affects postoperative outcomes such as pain, seroma, hematoma, infection, or overall recovery, while maintaining safety.
|
|
Aktiv komparator: thyroidectomy with drain
Participants in this arm undergo sutureless thyroidectomy for benign thyroid disease with placement of a subcutaneous suction drain at the end of the procedure.
The purpose of using the drain is to evacuate any postoperative fluid such as blood or serous fluid from the surgical site to theoretically reduce complications such as hematoma or seroma accumulation.
|
Participants undergo sutureless thyroidectomy for benign thyroid disease with placement of a subcutaneous suction drain.
The drain is intended to evacuate postoperative fluid (blood or serous fluid) to reduce the risk of complications such as hematoma or seroma formation.
The surgical technique itself follows conventional sutureless thyroidectomy principles.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of postoperative neck hematoma requiring intervention
Tidsramme: Within 48 hours postoperatively
|
Any postoperative cervical hematoma causing airway compromise or requiring surgical re-exploration or invasive evacuation
|
Within 48 hours postoperatively
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
1. Overall postoperative complication rate
Tidsramme: Within 30 days postoperatively
|
Definition: Composite of hematoma, seroma, wound infection, hypocalcemia, and recurrent laryngeal nerve injury
|
Within 30 days postoperatively
|
|
2. Seroma formation
Tidsramme: Within 14 days postoperatively
|
Clinically or ultrasonographically detected fluid collection requiring aspiration
|
Within 14 days postoperatively
|
|
3. Postoperative hypocalcemia
Tidsramme: Within 72 hours postoperatively
|
Corrected serum calcium < 8.5 mg/dL and/or symptoms requiring calcium supplementation
|
Within 72 hours postoperatively
|
|
Recurrent laryngeal nerve injury
Tidsramme: Within 30 days postoperatively
|
Postoperative vocal cord paresis/paralysis confirmed by laryngoscopy
|
Within 30 days postoperatively
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- MUFMIRB9251023
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Godartet Thyroid Nodule
-
Xijing HospitalIkke rekrutterer endnuPapillar Thyroid MicrocarcinomKina
-
University Hospital, GhentUniversitaire Ziekenhuizen KU Leuven; AZ Sint-Jan AVRekrutteringGodartet Thyroid NoduleBelgien
-
Premier G Med Cardio KftHungarian Ministry of Innovation and Technology; Semmelweis UniversityAfsluttetPapillar Thyroid MicrocarcinomUngarn
-
Suez UniversityIkke rekrutterer endnu
-
Alpha Fusion Inc.RekrutteringDTC - Differentieret Thyroid CancerJapan
-
Centre Hospitalier Universitaire de BesanconRekrutteringBenign bugspytkirtellæsionFrankrig
-
University of CalgaryIkke rekrutterer endnuBenign prostatahyperplasi | Benign prostatahyperplasi med symptomer i nedre urinveje | Benign prostatahyperplasi med udstrømningsobstruktionCanada
-
Ondokuz Mayıs UniversityIkke rekrutterer endnuBenign prostataobstruktion (BPO)Tyrkiet (Türkiye)
-
Ain Shams UniversityAfsluttetBenign gynækologisk sygdomEgypten
-
Campus Bio-Medico UniversityAfsluttetBenign gynækologisk patologi